News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
449,920 Results
Type
Article (24436)
Company Profile (159)
Press Release (425325)
Section
Business (141914)
Career Advice (1274)
Deals (27119)
Drug Delivery (94)
Drug Development (61139)
Employer Resources (93)
FDA (10060)
Job Trends (10362)
News (243830)
Policy (22010)
Tag
Academia (1147)
Alliances (33488)
Alzheimer's disease (824)
Approvals (10038)
Artificial intelligence (112)
Bankruptcy (256)
Best Places to Work (7893)
Biotechnology (80)
Breast cancer (148)
Cancer (1114)
Cardiovascular disease (93)
Career advice (1042)
Cell therapy (188)
Clinical research (50339)
Collaboration (362)
Compensation (163)
COVID-19 (1521)
Data (1160)
Diabetes (143)
Diagnostics (3397)
Drug pricing (98)
Earnings (61997)
Employer resources (86)
Events (68315)
Executive appointments (323)
FDA (10538)
Funding (315)
Gene therapy (145)
GLP-1 (570)
Government (2649)
Healthcare (10499)
Infectious disease (1600)
Inflammatory bowel disease (94)
Interviews (202)
IPO (12889)
Job creations (2833)
Job search strategy (923)
Layoffs (313)
Legal (5211)
Lung cancer (164)
Lymphoma (92)
Manufacturing (174)
Medical device (6327)
Medtech (6330)
Mergers & acquisitions (14394)
Metabolic disorders (430)
Neuroscience (1079)
NextGen Class of 2024 (3785)
Non-profit (1993)
Northern California (1242)
Obesity (258)
Opinion (194)
Patents (100)
People (38294)
Phase I (15496)
Phase II (21813)
Phase III (17087)
Pipeline (472)
Postmarket research (1889)
Preclinical (5676)
Radiopharmaceuticals (193)
Rare diseases (205)
Real estate (3946)
Regulatory (15198)
Research institute (1204)
Resumes & cover letters (207)
Southern California (1096)
Startups (2539)
United States (10988)
Vaccines (344)
Weight loss (211)
Date
Last 7 days (487)
Last 30 days (1840)
Last 365 days (25948)
2024 (25844)
2023 (28059)
2022 (36312)
2021 (37909)
2020 (35301)
2019 (29592)
2018 (22693)
2017 (22984)
2016 (21440)
2015 (25168)
2014 (19646)
2013 (16432)
2012 (17811)
2011 (18174)
2010 (16512)
Location
Africa (497)
Arizona (92)
Asia (30164)
Australia (4258)
California (2806)
Canada (1091)
China (246)
Colorado (118)
Connecticut (150)
Delaware (78)
Europe (63351)
Florida (373)
Illinois (263)
Indiana (167)
Japan (80)
Maryland (369)
Massachusetts (2212)
Michigan (122)
Minnesota (153)
New Jersey (892)
New York (841)
North Carolina (594)
Northern California (1242)
Ohio (99)
Pennsylvania (612)
South America (763)
Southern California (1096)
Texas (425)
Washington State (283)
449,920 Results for "7 hills pharma llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the Clinic
7 Hills Pharma Inc., a clinical-stage pharma company leveraging a novel mechanism of action to safely enhance the effectiveness of cancer immunotherapies, was awarded $4.7 million from the Cancer Prevention and Research Institute of Texas to support its cell/gene therapy development program.
June 3, 2024
·
5 min read
Press Releases
Boston Institute of Biotechnology, LLC with BiBo Pharma Announce Groundbreaking Expansion to Revolutionize Global Biologics Production Capacity
December 20, 2024
·
3 min read
Drug Development
7 Hills Pharma Safely Doses First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors
September 3, 2024
·
2 min read
Lone Star Bio
7 Hills Pharma Surpasses $25MM Milestone in Nondilutive Funding
7 Hills Pharma LLC announced that it has been awarded $13.5MM in nondilutive grant funds from the Cancer Prevention & Research Institute of Texas to advance 7HP349, its first-in-class oral selective integrin activator into a Phase 1b/2a clinical trial in patients who are resistant to PD-1-based therapies.
May 22, 2023
·
4 min read
Business
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.
November 27, 2024
·
9 min read
·
Annalee Armstrong
Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
Zealand Pharma A/S announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.
January 10, 2024
·
1 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
1 of 44,992
Next
